Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

MHRA issues fresh warning on homeopathy for serious conditions

Homeopathy poses a threat if advocated for the treatment or prevention of serious conditions, the MHRA has stated, in the latest twist to the homeopathy debate.

The comments follow a report on Channel 4 regarding the use of homeopathic remedies to prevent malaria.The Royal Pharmaceutical Society appeared on BBC’s Newsnight on January 4 stating there was no scientific or clinical evidence to support the efficacy of homeopathic products.In its strong statement against the use of homeopathy for the treatment of serious conditions, the MHRA issued a reminder yesterday that it had removed products used for the prevention of malaria and treatment of cancer from the market in previous years.Last year the BMA called for the funding of homeopathic remedies to be dropped by the NHS, and the remedies have continued to spark controversy.The MHRA stated that it is important that they regulate homeopathic products so that they could intervene in situations where regulations were abused.“Registration of homeopathic products for marketing is conditional on quality and safety criteria, evidence that the product is indeed a homeopathic product as recognised by homeopaths, and that the labelling National Rules products does not include any other indication than a minor self limiting condition,” the MHRA explained.To view the BBC Newsnight programme on homeopathy click here and go to 15.50 minutes into the programme

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD013595

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel